Xencor, Inc.
NASDAQ: XNCR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bassil I. Dahiyat
- Employees
- 250
- Headquarters
- Pasadena, United States
- IPO year
- 2013
- Market cap
- $1.1B
- Website
- https://www.xencor.com
Loading XNCR…
Loading profile data…Frequently asked questions about XNCR
What does Xencor, Inc. (XNCR) do?
Xencor Inc., a biopharmaceutical firm headquartered in Monrovia, California, and established in 1997, operates as a clinical-stage entity. Its central mission involves the discovery and sophisticated engineering of monoclonal antibody and cytokine therapeutics, primarily aimed at treating patients afflicted with cancer and autoimmune disorders....
Where does XNCR trade?
Xencor, Inc. (XNCR) trades on the NASDAQ Global Market.
What sector is XNCR in?
Xencor, Inc. (XNCR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Xencor, Inc.?
Bassil I. Dahiyat is the chief executive officer of Xencor, Inc. (XNCR).
Where is Xencor, Inc. headquartered?
Xencor, Inc. is headquartered in United States.
Does XNCR pay a dividend?
Xencor, Inc. (XNCR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XNCR go public?
Xencor, Inc. (XNCR) completed its initial public offering in 2013.